Pediatric Femur Fracture Registry

NCT ID: NCT03211546

Last Updated: 2025-08-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

322 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-14

Study Completion Date

2024-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective data collection and evaluation of complete data sets will be performed in the course of routine clinical care of a cohort of consecutive patients (children up to 16 years old) presenting with an isolated femur shaft fracture. Data will be collected during follow-up visits at 3 to 6 weeks, 3, 6, 12 and 24 months, with additional follow-up visits as needed or dictated by individual practice. Final follow-up will be at 24 months, unless a patient requires additional follow-up or another intervention to address an unfavorable outcome (e.g. malalignment, nonunion, limb length discrepancy) noted at the 24 month follow-up visit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There is limited evidence about the comparative effectiveness of different treatments for pediatric femur fractures. The most common method used for isolated femur shaft fractures of children older than 5 years of age is elastic stable intramedullary nailing (ESIN). It is thought to be the ideal indication for children up to the age of 10 to 12 and it is the most commonly employed method of internal fixation in this age group, but other treatments include external fixation, plating, other forms of flexible or rigid intramedullary nailing and non-operative options such as spica casts or traction. In children under the age of 5 non-operative methods are believed to work well with few complications. Imperfect alignment is more acceptable because of the tremendous remodelling potential in young growing children. Internal fixation is believed to be unnecessary as it is more invasive, with some risk of complications and likely need for a second surgical procedure to remove it. Biomechanical properties are different in this age group. Consequently, operative treatment of these fractures is generally not recommended in children under the age of 3 according to the German guidelines (www.awmf.org), not under the age of 5 in the American guidelines (www.aaos.org); and in Great Britain, surgical management in preschool children is restricted to polytrauma and complex injuries (www.nice.org.uk).

Despite these recommendations and the general acceptance of non-operative treatment for younger children , a survey of clinical practice in Germany revealed that 50% of children under the age of 3 years are treated with ESIN, because some surgeons believe that patients seem less comfortable when treated with traction or spica casting and might experience a higher rate of loss of reduction. Consequently, the use of ESIN for fractures in preschool children has become more prevalent in the last years.

Similarly, there is wide variation in the preferred management of femoral shaft fractures in older children, with little evidence about the comparative effectiveness of different treatments for pediatric femur fractures. There is an imperative to collect prospective data to generate higher quality evidence.

The purpose of this proposed registry is to collect the clinical outcomes (fracture healing \& patient reported outcomes and complications) of the treatment of isolated femur shaft fractures in children up to skeletal maturity. Additionally, health economic aspects will be evaluated to give possible recommendations from a health economic perspective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Shaft Fracture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Femoral shaft fracture

Patients (children up to 16 years old) diagnosis of isolated closed femur shaft fracture (3.2-D) and open distal physis. Treatment strategies will follow standard of care (routine) procedures, either conservative (non-surgical) treatment or surgical treatment.

Conservative (non-surgical) treatment

Intervention Type PROCEDURE

Spica cast Traction Traction and spica cast

Surgical treatment

Intervention Type PROCEDURE

Elastic Stable Intramedullary Nailing (ESIN) Conventional locking intramedullary nail Plating External fixation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Conservative (non-surgical) treatment

Spica cast Traction Traction and spica cast

Intervention Type PROCEDURE

Surgical treatment

Elastic Stable Intramedullary Nailing (ESIN) Conventional locking intramedullary nail Plating External fixation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age less than 16 years of age at the time of the injury
* Open distal physis of the femur
* Diagnosis of isolated closed femur shaft fracture (3.2-D)
* Willingness and ability of the patient/parents/legally responsible care giver to participate in the clinical investigation including imaging and FU procedures as standard of care in each clinic
* Willingness and ability of the parent(s) to support the patient in his/her study participation
* Ability of parents to understand the content of the patient information / ICF and participation in the clinical investigation
* Signed ICF by patient and/or parent(s) according to local policies and regulations

Exclusion Criteria

* Polytraumatized patient
* Closed distal physis of the femur
* Pathologic fractures and fractures in patients with metabolic bone disease, osteogenesis imperfecta, neuromuscular disorder, endocrinologic disease or other conditions influencing the bony structure
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Innovation Translation Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter P. Schmittenbecher, Prof.

Role: PRINCIPAL_INVESTIGATOR

Kinderchirurgische Klinik, Klinikum Karlsruhe

Unni G. Narayanan, Prof.

Role: PRINCIPAL_INVESTIGATOR

The Hospital for Sick Children, Toronto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boston Children's Hospital

Boston, Massachusetts, United States

Site Status

Medical University Hospital of Graz

Graz, , Austria

Site Status

BC Children's Hospital

Vancouver, British Columbia, Canada

Site Status

IWK Health Centre

Halifax, New Scotland, Canada

Site Status

Children's Hospital of Eastern Ontario (CHEO)

Ottawa, Ontario, Canada

Site Status

The Hospital for Sick Children

Toronto, Ontario, Canada

Site Status

Universitätsklinik Dresden

Dresden, , Germany

Site Status

University Medicine Göttingen (UMG)

Göttingen, , Germany

Site Status

Altonaer Kinderkrankenhaus GmbH

Hamburg, , Germany

Site Status

Städt. Klinikum Karlsruhe

Karlsruhe, , Germany

Site Status

University of Leipzig

Leipzig, , Germany

Site Status

University Hospital Tübingen

Tübingen, , Germany

Site Status

Inselspital

Bern, , Switzerland

Site Status

Childrens Hospital Zurich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Austria Canada Germany Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PedFemFx

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Home Management of Pediatric Buckle Fractures
NCT06633094 ACTIVE_NOT_RECRUITING NA